|
|
|
A condition marked by fever and a lower-than-normal number of neutrophils in the blood. A neutrophil is a type of white blood cell that helps fight infection. Having too few neutrophils increases the risk of infection. ... Print This Page ... More NCI Dictionaries...
|
www.cancer.gov/Templates/db_alpha.aspx?CdrID=415543
|
|
|
|
|
|
A thorough history is extremely important when evaluating patients for febrile neutropenia. ... Management of febrile neutropenia MANAGING SIDE EFFECTS patients can be treated as outpatients;
|
www.communityoncology.net/journal/articles/0309585.pdf
|
|
|
|
Compare Febrile Neutropenia related medications. Comprehensive Febrile Neutropenia information for consumers and professionals including user ratings, reviews and drug dosage information. ... Drugs associated with Febrile Neutropenia...
|
www.drugs.com/condition/febrile-neutropenia.html
www.drugs.com/condition/febrile-neutropenia.html
|
|
|
One technical term of which cancer patients should be aware is "Febrile Neutropenia," which refers to having a fever while the white blood cell count is low. Fever indicates the presence of an infection, which, in most cases, originates from germs and bacteria that reside in the intestines or skin.
|
www.tirgan.com/leucpnia.htm
|
|
Aquino and colleagues examined the efficacy of using ciprofloxacin in the outpatient management of selected pediatric patients with fever during an episode of neutropenia. ... In this study, carefully selected, low-risk patients with febrile neutropenia were treated successfully without hospitalization.
|
www.aafp.org/afp/20001001/tips/18.html
|
|
An open labeled randomized trial comparing the efficacy and cost of empirically applied cefepime (C) as monotherapy versus combination therapy consisting of ticarcillin and clavulanate potassium and aztreonam (T/A) was performed in febrile neutropenic patients following high-dose chemotherapy (HDC) +/- radiation,
|
www.medscape.com/medline/abstract/12796602
|
|
Fever and Neutropenia (FEV-1); Initial Therapy (FEV-2); Initial Risk Assessment for the Febrile; Neutropenic Patients (FEV-3); Mouth, Esophagus and Sinus/Nasal (FEV-4); Abdominal Pain, Perirectal Pain, Diarrhea, Vascular Access Devices (FEV-5);
|
www.oralcancerfoundation.org/treatment/pdf/infections-N...
www.oralcancerfoundation.org/treatment/pdf/infections-NCCN.pdf
|
|
